Charles Schwab’s Endava DAVA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$201K Sell
71,137
-32,613
-31% -$120K ﹤0.01% 3370
2026
Q1
$459K Buy
103,750
+610
+0.6% +$3.37K ﹤0.01% 3129
2025
Q4
$652K Buy
103,140
+43,640
+73% +$334K ﹤0.01% 3078
2025
Q3
$541K Buy
59,500
+19,645
+49% +$245K ﹤0.01% 3148
2025
Q2
$611K Buy
39,855
+2,810
+8% +$47.3K ﹤0.01% 3070
2025
Q1
$723K Buy
37,045
+9,756
+36% +$271K ﹤0.01% 2956
2024
Q4
$843K Buy
27,289
+7,124
+35% +$195K ﹤0.01% 2970
2024
Q3
$515K Buy
20,165
+11,020
+121% +$331K ﹤0.01% 3147
2024
Q2
$267K Buy
+9,145
New +$271K ﹤0.01% 3393

Other funds holding DAVA

Charles Schwab's DAVA Position: Q2 2026 in Review

Charles Schwab reduced its Endava (DAVA) stake by 31% in Q2 2026, selling an estimated $120K and leaving 71,137 shares worth $201K. The position accounts for ﹤0.01% of the portfolio, ranked #3370.

Charles Schwab first reported a position in DAVA in Q2 2024 and has held it in 9 quarters since. The position peaked at $843K in Q4 2024. 72 funds tracked by Wall St. Rank hold DAVA as of Q2 2026.

  • Charles Schwab held 71,137 shares of Endava worth $201K as of Q2 2026.
  • Charles Schwab sold 32,613 Endava shares in Q2 2026, an estimated $120K.
  • Endava made up ﹤0.01% of Charles Schwab's portfolio in Q2 2026, its #3370 holding.
  • Charles Schwab first reported a position in Endava in Q2 2024 and has held it in 9 quarters since.
  • Charles Schwab's Endava position peaked at $843K in Q4 2024.
  • 72 funds tracked by Wall St. Rank held Endava as of Q2 2026.

Based on Charles Schwab's 13F filing for Q2 2026, filed 14 Aug 2026.